Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Is Selenium Deficiency the Cause of Uraemic Cardiomyopathy?

    We studied the relationship between serum selenium (Se) and left ventricular performance in 33 patients on maintenance haemodialysis. Low serum Se was frequent. However, there were no significant differences i...

    E. R. Maher, B. Sampson, J. R. Curtis in Uremic Toxins (1987)

  2. Article

    Ophthalmological screening for von Hippel-Lindau disease

    Forty seven individuals (from 16 kindreds) without prior evidence of retinal hae-mangiomas underwent full ophthalmological assessment as part of a comprehensive screening programme for Von Hippel-Lindau diseas...

    A T Moore, E R Maher, P Rosen, Z Gregor, A C Bird in Eye (1991)

  3. No Access

    Article

    Physical map** of chromosome 3p25-p26 by flourescence in situ hybridisation (FISH)

    As part of our effort to isolate and characterise the von Hippel-Lindau (VHL) disease gene, we constructed a physical map of chromosome 3p25-26 by fluorescence in situ hybridisation (FISH) studies on a panel o...

    M. E. Phipps, E. R. Maher, N. A. Affara, F. Latif, M. A. Leversha in Human Genetics (1993)

  4. No Access

    Chapter

    Molecular Genetics of Wilms’ Tumour and Renal Cell Carcinoma

    It is now generally accepted that cancer is caused by an accumulation of genetic mutations. However, only a small proportion of cancer-associated gene mutations are inherited (i.e. are germline mutations); the...

    E. R. Maher in Tumours in Urology (1994)

  5. No Access

    Article

    Irish college of ophthalmologists

    N. Abdulla, B. Lanigan, M. O’Keefe, R. Bowell in Irish Journal of Medical Science (1995)

  6. No Access

    Article

    Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene

    Experimental conditions for detection of germline deletions of the von Hippel-Lindau (VHL) gene by means of long polymerase chain reaction have been established. Primers were designed to analyse the VHL gene i...

    C. Cybulski, K. Krzystolik, E.R. Maher, S. Richard, G. Kurzawski in Human Genetics (1999)

  7. No Access

    Article

    Analysis of the TSC1and TSC2genes in sporadic renal cell carcinomas

    The genetic events involved in the aetiology of non-clear-cell renal cell carcinoma (RCC) and a proportion of clear cell RCC remain to be defined. Germline mutations of the TSC1and TSC2genes cause tuberous sclero...

    L Parry, J H Maynard, A Patel, S C Clifford, C Morrissey in British Journal of Cancer (2001)

  8. Article

    Open Access

    SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

    The 3p21.3 RASSF1A tumour suppressor gene (TSG) provides a paradigm for TSGs inactivated by promoter methylation rather than somatic mutations. Recently, we identified frequent promoter methylation without somati...

    D Astuti, N F da Silva, A Dallol, D Gentle, T Martinsson in British Journal of Cancer (2004)

  9. Article

    Open Access

    Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma

    Germline mutations in the succinate dehydrogenase (SDH) (mitochondrial respiratory chain complex II) subunit B gene, SDHB, cause susceptibility to head and neck paraganglioma and phaeochromocytoma. Previously, we...

    D Astuti, M Morris, C Krona, F Abel, D Gentle, T Martinsson in British Journal of Cancer (2004)

  10. Article

    Open Access

    Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers

    In Drosophila, the Slit gene product, a secreted glycoprotein, acts as a midline repellent to guide axonal development during embryogenesis. Three human Slit gene orthologues have been characterised and recent...

    R E Dickinson, A Dallol, I Bieche, D Krex, D Morton, E R Maher in British Journal of Cancer (2004)

  11. Article

    Open Access

    Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour

    Epigenetic alterations in the 11p15.5 imprinted gene cluster are frequent in human cancers and are associated with disordered imprinting of insulin-like growth factor (IGF)2 and H19. Recently, an imprinted gene c...

    D Astuti, F Latif, K Wagner, D Gentle, W N Cooper in British Journal of Cancer (2005)

  12. No Access

    Article

    Identification of novel VHL targets that are associated with the development of renal cell carcinoma

    von Hippel–Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and central nervous system haemangioblastomas, renal cell carcinoma (RCC) and phaeoc...

    M Abdulrahman, E N Maina, M R Morris, M Zatyka, R R Raval, R E Banks in Oncogene (2007)

  13. Article

    Open Access

    Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

    Promoter region hypermethylation and transcriptional silencing is a frequent cause of tumour suppressor gene (TSG) inactivation in many human cancers. Previously, to identify candidate epigenetically inactivat...

    M R Morris, D Gentle, M Abdulrahman, N Clarke, M Brown in British Journal of Cancer (2008)

  14. No Access

    Article

    Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

    RASSF2 is a recently identified member of a class of novel tumour suppressor genes, all containing a ras-association domain. RASSF2 resides at 20p13, a region frequently lost in human cancers. In this report w...

    W N Cooper, R E Dickinson, A Dallol, E V Grigorieva, T V Pavlova, L B Hesson in Oncogene (2008)

  15. No Access

    Article

    SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis

    Mutations in SDHB are one of the causes of hereditary paraganglioma syndrome. Germline mutations in SDHB predispose to the development of head and neck paragangliomas and phaeochromocytomas. Renal tumours are ...

    Alex Henderson, F. Douglas, P. Perros, C. Morgan, E. R. Maher in Familial Cancer (2009)

  16. No Access

    Article

    Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma

    Promoter region hyermethylation and transcriptional silencing is a frequent cause of tumour suppressor gene (TSG) inactivation in many types of human cancers. Functional epigenetic studies, in which gene expre...

    M R Morris, C Ricketts, D Gentle, M Abdulrahman, N Clarke, M Brown, T Kishida in Oncogene (2010)

  17. No Access

    Article

    The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways

    The Ras-assocation domain family (RASSF) of tumor suppressor proteins until recently contained six proteins named RASSF1–6. Recently, four novel family members, RASSF7–10, have been identified by homology searche...

    F E Lock, N Underhill-Day, T Dunwell, D Matallanas, W Cooper, L Hesson in Oncogene (2010)

  18. No Access

    Article

    Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis

    We have recently described the N-terminal RAS association domain family of genes, RASSF7–10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5′-CpG island...

    V K Hill, N Underhill-Day, D Krex, K Robel, C B Sangan, H R Summersgill in Oncogene (2011)

  19. No Access

    Article

    Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

    The detection of promoter region hypermethylation and transcriptional silencing has facilitated the identification of candidate renal cell carcinoma (RCC) tumour suppressor genes (TSGs). We have used a genome-...

    M R Morris, C J Ricketts, D Gentle, F McRonald, N Carli, H Khalili, M Brown in Oncogene (2011)

  20. No Access

    Article

    Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

    The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples o...

    A. Moran, C. O’Hara, S. Khan, L. Shack, E. Woodward, E. R. Maher in Familial Cancer (2012)

previous disabled Page of 2